Intézmény

Universitair Ziekenhuis Leuven

Leuven, BelgiumHonlap

Más néven: UZ Leuven

789futó vizsgálat
374lezárt vizsgálat
50 849publikáció (OpenAlex)

Futó vizsgálatok

Még nem toboroz
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás
Még nem toboroz
A study to learn how dapirolizumab pegol transfers to babies from pregnant mothers with active systemic lupus erythematosus
2025-524595-37-00· 1. fázis· UCB Biopharma· Forrás
Még nem toboroz
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás
Még nem toboroz
Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement
NCT07877298· University Hospital Muenster· Forrás
Még nem toboroz
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás
Még nem toboroz
The CORE Platform Trial
NCT07892976· Copenhagen Trial Unit, Center for Clinical Intervention Research· Forrás
Még nem toboroz
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
NCT07738887· 2. fázis· The Lymphoma Academic Research Organisation· Forrás
Még nem toboroz
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás
Még nem toboroz
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
2025-523400-72-00· 2. fázis· Vertex Pharmaceuticals Inc.· Forrás
Még nem toboroz
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
NCT07789015· 3. fázis· Boehringer Ingelheim· Forrás
Még nem toboroz
Assessment of self-perceived stress and repetitive behaviors after six weeks of daily intranasal oxytocin administration versus placebo: a randomised, multicentre, parallel group pragmatic trial in 210 men and women with autism
2025-524797-42-00· 3. fázis· UZ Leuven· Forrás
Még nem toboroz
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás
Toboroz
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
NCT07781657· 2. fázis· Hoffmann-La Roche· Forrás
Még nem toboroz
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
NCT07919405· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás
Még nem toboroz
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás
Toboroz
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
2026-525197-19-00· 2. fázis· Agomab Spain S.L.U.· Forrás
Toboroz
Phase 3 Study of Azenosertib Versus Chemotherapy in Platinum-Resistant Ovarian Cancers Positive for Cyclin E1 Protein Expression
2025-524641-27-00· 3. fázis· K-Group Beta Inc.· Forrás
Toboroz
STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma
NCT07863258· Universitaire Ziekenhuizen KU Leuven· Forrás
Toboroz
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).
2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás
Toboroz
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás
Toboroz
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
NCT07587658· 4. fázis· Regeneron Pharmaceuticals· Forrás
Még nem toboroz
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás
Még nem toboroz
Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer [18F]-AlF-FAPI-74 versus power doppler ultrasound in psoriasis patients with arthralgia: early detection of psoriatic arthritis
2026-526942-29-00· 2/3. fázis· UZ Leuven· Forrás
Még nem toboroz
Attachment Development and Learning in ADHD: The role of Dopamine
2025-525122-35-00· 4. fázis· UZ Leuven· Forrás
Toboroz
Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
NCT07876648· 2. fázis· Universitaire Ziekenhuizen KU Leuven· Forrás
Toboroz
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
NCT07441200· 2. fázis· NS Pharma, Inc.· Forrás
Toboroz
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
NCT07768189· 3. fázis· Corbus Pharmaceuticals Inc.· Forrás
Toboroz
ENDO-REAL: Endometriosis and Reproductive Enhancement with Letrozole
2025-524995-53-00· 4. fázis· UZ Brussel· Forrás
Toboroz
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
NCT07817875· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
2026-525489-23-00· 3. fázis· Amgen Inc.· Forrás
Toboroz
Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation
NCT07753148· 1. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07701941· 1/2. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193· 2. fázis· Vividion Therapeutics, Inc.· Forrás
Toboroz
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161· 3. fázis· Takeda· Forrás
Még nem toboroz
Rehabilitation Through Individualized Support and Exercise
NCT07857096· Universitaire Ziekenhuizen KU Leuven· Forrás
Toboroz
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· 3. fázis· Incyte Corporation· Forrás
Toboroz
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás
Toboroz
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215· 2. fázis· Bayer· Forrás
Toboroz
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
NCT07587242· 3. fázis· Avidity Biosciences, Inc.· Forrás
Toboroz
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
NCT07405671· 4. fázis· Universitaire Ziekenhuizen KU Leuven· Forrás
Még nem toboroz
Targeted Muscle Activation During Strength Training for Children With CP
NCT07800221· Universitaire Ziekenhuizen KU Leuven· Forrás
Toboroz
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
NCT07630714· 2. fázis· AstraZeneca· Forrás
Toboroz
A neuropsychobiological approach to optimize patient selection for GLP-1-based pharmacotherapy for weight management across the binge eating spectrum
2026-526016-36-00· 4. fázis· UZ Leuven· Forrás
Toboroz
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465· 3. fázis· Kardigan, Inc.· Forrás
Toboroz
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
A clinical trial of MK-8210 in healthy participants (MK-8210-001)
2026-527022-13-00· 1. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
2025-525105-20-00· 1/2. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás
Toboroz
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Még nem toboroz
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
NCT07760818· 2. fázis· argenx· Forrás

Showing 50 of 789.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Tüdőrák38 toboroz
Gyermekkori daganatok35 toboroz
Petefészekrák28 toboroz
Vastagbélrák26 toboroz
Crohn-betegség25 toboroz
Áttétes emlőrák19 toboroz
Colitis ulcerosa16 toboroz
Hasnyálmirigyrák16 toboroz
Méhtestrák14 toboroz
Prosztatarák14 toboroz
Gyomor- és nyelőcsőrák13 toboroz
Magas vérnyomás13 toboroz
Akut mieloid leukémia (AML)12 toboroz
Elhízás11 toboroz
Koszorúér-betegség11 toboroz
Amiotrófiás laterálszklerózis (ALS)10 toboroz
Duchenne-izomdisztrófia10 toboroz
Fej-nyaki daganatok10 toboroz
Krónikus limfoid leukémia (CLL)10 toboroz
Parkinson-kór10 toboroz
Stroke (szélütés)10 toboroz
Máj- és epeúti rák9 toboroz
Mielóma multiplex9 toboroz
Pitvarfibrilláció9 toboroz
Szívelégtelenség9 toboroz
Alzheimer-kór8 toboroz
Melanóma8 toboroz
Rheumatoid arthritis8 toboroz
Cerebral palsy7 toboroz
Hólyagrák7 toboroz
Idiopátiás tüdőfibrózis7 toboroz
Lupus (SLE)7 toboroz
Myotonic dystrophy7 toboroz
Pulmonális artériás hipertónia7 toboroz
1-es típusú cukorbetegség6 toboroz
Krónikus obstruktív tüdőbetegség (COPD)6 toboroz
Mielodiszplasztikus szindróma (MDS)6 toboroz
Pikkelysömör6 toboroz
Szarkóma6 toboroz
Tripla negatív emlőrák6 toboroz
2-es típusú cukorbetegség5 toboroz
Akut limfoid leukémia (ALL)5 toboroz
Amiloidózis5 toboroz
Mieloproliferatív neopláziák5 toboroz
Myasthenia gravis5 toboroz
Vesedaganat5 toboroz
Arthritis psoriatica4 toboroz
Dilated cardiomyopathy4 toboroz
Glioblasztóma4 toboroz
Krónikus vesebetegség4 toboroz
Lewy-testes demencia4 toboroz
Méhnyakrák4 toboroz
Neuroendokrin daganatok4 toboroz
Osteoarthritis4 toboroz
Peripheral artery disease4 toboroz
Autizmus spektrumzavar3 toboroz
Cisztás fibrózis3 toboroz
Diffúz nagy B-sejtes limfóma (DLBCL)3 toboroz
Endometriózis3 toboroz
Hemofília3 toboroz
Hodgkin-limfóma3 toboroz
Huntington-kór3 toboroz
Irritable bowel syndrome3 toboroz
Krónikus gyulladásos demielinizációs polineuropátia (CIDP)3 toboroz
Krónikus mieloid leukémia (CML)3 toboroz
Liver cirrhosis3 toboroz
Policisztás vesebetegség3 toboroz
Sjögren-szindróma3 toboroz
Spondylitis ankylopoetica (Bechterew-kór)3 toboroz
Szisztémás szklerózis (szkleroderma)3 toboroz
Aortic stenosis2 toboroz
Brain metastases2 toboroz
Bronchiectasis2 toboroz
Dermatomyositis and polymyositis (myositis)2 toboroz
Epilepszia2 toboroz
Fabry-betegség2 toboroz
Frontotemporális demencia2 toboroz
Gestational diabetes2 toboroz
Hidradenitis suppurativa2 toboroz
Mitochondrial disease2 toboroz
Multiple system atrophy2 toboroz
Neuroblasztóma2 toboroz
Pituitary tumours2 toboroz
Pompe-betegség2 toboroz
Primer biliáris cholangitis (PBC)2 toboroz
Asztma1 toboroz
Barrett's oesophagus1 toboroz
Bipoláris zavar1 toboroz
Chronic rhinosinusitis with nasal polyps1 toboroz
Chronic spontaneous urticaria1 toboroz
Coeliac disease1 toboroz
Congenital heart disease1 toboroz
Csontritkulás1 toboroz
Cytomegalovirus infection1 toboroz
Depresszió1 toboroz
Diabetic foot ulcer1 toboroz
Eosinophilic oesophagitis1 toboroz
Epidermolysis bullosa1 toboroz
Familiáris hiperkoleszterinémia1 toboroz
Follikuláris limfóma1 toboroz
Gastroparesis1 toboroz
Giant cell arteritis1 toboroz
Hearing loss1 toboroz
HIV-fertőzés1 toboroz
Időskori makuladegeneráció1 toboroz
IgA-nefropátia1 toboroz
Meningioma1 toboroz
Myocarditis1 toboroz
Narcolepsy1 toboroz
Obstructive sleep apnoea1 toboroz
Osteonecrosis (avascular necrosis)1 toboroz
Sarlósejtes vérszegénység1 toboroz
Sclerosis multiplex (SM)1 toboroz
Skizofrénia1 toboroz
Spinal cord injury1 toboroz
Spinális izomatrófia (SMA)1 toboroz
Testicular cancer1 toboroz
Ventricular tachycardia1 toboroz
Zöldhályog (glaukóma)1 toboroz
Zsírmáj (MASLD/MASH)1 toboroz

Lezárt vizsgálatok

Leállították
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
NCT06595563· 2. fázis· Jules Bordet Institute· Forrás
Még nem toboroz
HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
2025-524230-25-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás
Lezárult
A clinical trial of MK-1824 in healthy participants (MK-1824-001)
2026-525748-14-00· 1. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis
NCT07222189· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás
Lezárult
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
2025-522867-13-00· 2. fázis· Merus B.V.· Forrás
Fut, nem toboroz
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps
NCT07424144· 3. fázis· Sanofi· Forrás
Lezárult
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489
2025-521155-23-00· 2. fázis· Pfizer Inc.· Forrás
Lezárult
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations
2025-521480-12-00· 1. fázis· Atavistik Bio Inc.· Forrás
Toboroz
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262· 2. fázis· CSL Behring· Forrás
Toboroz
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
2024-520201-39-00· 2. fázis· Odyssey Therapeutics Inc.· Forrás
Leállították
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
NCT06987968· 2. fázis· Genfit· Forrás
Lezárult
Implementation of the MOX Activity Monitor in Hospitalized Geriatric Rehabilitation
NCT07124247· KU Leuven· Forrás
Lezárult
A Study With CIT-013 in RA Patients
NCT06567470· 2. fázis· Citryll BV· Forrás
Lezárult
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660· 2. fázis· Boehringer Ingelheim· Forrás
Toboroz
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
NCT06699849· 2. fázis· CSL Behring· Forrás
Lezárult
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
NCT06867094· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás
Lezárult
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
2024-518364-12-00· 2. fázis· Immunovant Sciences GmbH· Forrás
Lezárult
A Study to see How Well and How Safely Different Treatments Work in a Group of Patients with Non-Small Cell Lung Cancer, Chosen Based on their Biomarker Status
2024-511239-91-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás
Lezárult
A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KRAS-G12D mutation, when given alone and with other cancer drugs
NCT06599502· 1/2. fázis· AstraZeneca AB· Forrás
Lezárult
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)
NCT06684847· 3. fázis· Argenx· Forrás
Lezárult
A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis
2023-507771-22-01· 3. fázis· Intercept Pharmaceuticals Inc.· Forrás
Fut, nem toboroz
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
NCT06840483· 2. fázis· BicycleTx Limited· Forrás
Fut, nem toboroz
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920· 3. fázis· Novartis Pharmaceuticals· Forrás
Lezárult
A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy
2023-508998-85-00· 1. fázis· Boehringer Ingelheim International GmbH· Forrás
Fut, nem toboroz
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
NCT06632951· 2. fázis· AbbVie· Forrás
Fut, nem toboroz
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
NCT06593522· 2. fázis· Amgen· Forrás
Lezárult
A clinical study of MK-2420 in healthy men (MK-2420-003)
2024-518104-47-00· 1. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
Smart MDI Study (CIP343)
NCT06645834· Medtronic MiniMed, Inc.· Forrás
Lezárult
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Lezárult
A safety and efficacy study of ARGX-119 in adult patients with Amyotrophic Lateral Sclerosis (ALS) (reALiSe)
NCT06441682· 2. fázis· Argenx· Forrás
Fut, nem toboroz
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT06321601· 3. fázis· Amgen· Forrás
Lezárult
A Study of TAK-861 in People With Narcolepsy Type 1
NCT06505031· 3. fázis· Takeda· Forrás
Visszavonták
3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS
NCT06409117· Konstantinos Toutouzas· Forrás
Lezárult
A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa
2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás
Fut, nem toboroz
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
NCT06315751· 2. fázis· Noema Pharma AG· Forrás
Lezárult
Safety and Efficacy of NMD670 in Adult Patients with Type 1 and Type 2 Charcot-Marie-Tooth Disease
2023-507892-23-00· 2. fázis· NMD Pharma A/S· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás
Lezárult
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease
NCT06522997· 2. fázis· Bayer· Forrás
Lezárult
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction
2023-508736-62-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás
Fut, nem toboroz
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616· 2. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás
Toboroz
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575· 3. fázis· Jazz Pharmaceuticals· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
2023-507539-40-00· 2. fázis· NMD Pharma A/S· Forrás
Lezárult
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás
Fut, nem toboroz
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580· 3. fázis· Vor Biopharma· Forrás
Lezárult
Add-on Clioquinol in drug-resistant epilepsy: an exploratory study
2024-511388-27-04· 2. fázis· UZ Leuven· Forrás
Fut, nem toboroz
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128· 3. fázis· Sanofi· Forrás
Leállították
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
NCT06488911· 3. fázis· Intercept Pharmaceuticals· Forrás
Lezárult
Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction
2023-506210-40-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation
NCT06503770· Zambon SpA· Forrás
Lezárult
Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )
NCT06341712· 2. fázis· Ipsen Innovation· Forrás

Showing 50 of 374.

Regiszterbeli névváltozatok (117)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

UZ Leuven
Leuven, 3000
1063 vizsgálat
Universitair Ziekenhuis Leuven
Leuven, 3000
27 vizsgálat
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, 3000
19 vizsgálat
Universitair Ziekenhuis (Uz) Leuven
Leuven, 03000
9 vizsgálat
UZ Leuven - Endocrinology
Leuven, 3000
4 vizsgálat
UZ Leuven - Gasthuisberg Campus
Leuven, 3000
3 vizsgálat
- NCT07768189A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
  Contact: Clinical Study Coordinator
- NCT06522737A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
  Contact: Koen Debackere (principal investigator)
- NCT03283085A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
UZ Leuven
Pellenberg, 3212
2 vizsgálat
- NCT03631706M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)
- NCT03372278PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
UZ Leuven - Hart en Vaatziekten
Leuven, 3000
2 vizsgálat
- NCT04560998A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
- NCT03745924A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
UZ Leuven - Kindergeneeskunde
Leuven, 3000
2 vizsgálat
- NCT05685238A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
- NCT05053139A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors
UZ Leuven/KU Leuven
Leuven, 3000
2 vizsgálat
- NCT07413614The Acute Effect of Exercise Type And Timing on Ambulatory Blood Pressure and Intra-Ocular Pressure in Individuals With Glaucoma (The ACHIEVE-project).
  Contact: Marie Renier, MSc
- NCT07666113Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
  Contact: Serafien D'hooge, MD
UZ Leuven - PPDS
Leuven, 3000
2 vizsgálat
- NCT07294170ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
  Contact: Kristl Claeys, MD
- NCT06243731A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
  Contact: Dirk Kuypers (principal investigator)
0560036 - Universitair Ziekenhuis Leuven
Leuven, 3000
1 vizsgálat
- NCT03473223Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
KU/UZ Leuven
Leuven, 3000
1 vizsgálat
- NCT07211750Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT
  Contact: Louise de Almeida Ferreira Fonseca
Universitaire Ziekenhuizen Leuven (UZ Leuven)
Leuven, B-3000
1 vizsgálat
- NCT06503770A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation
Universitaire Ziekenhuizen Leuven/ UZ Leuven/ UZL
Leuven, 3000
1 vizsgálat
- NCT06634628iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
  Contact: Wim Vandenberghe, MD, PhD
Universitaire Ziekenhuizen (Uz) Leuven - Campus Gasthuisberg - Multidisciplinair Borstcentrum (Multidisciplinary Breast Center) (Mbc)
Leuven, 03000
1 vizsgálat
- NCT05563220Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg
Leuven, 3000
1 vizsgálat
- NCT03025308Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Universitair Ziekenhuis Leuven (Adults and Pediatrics)
Leuven, Flemish Brabant 3000
1 vizsgálat
- NCT03394365A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
  Contact: Data Protection Officer
Universitair Ziekenhuis Leuven - Gasthuisberg
Leuven, 3000
1 vizsgálat
- NCT02675231A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
Universitair Ziekenhuis Leuven /ID# 124980
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT02163694A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
Universitair Ziekenhuis Leuven /ID# 127984
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT01848561A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Universitair Ziekenhuis Leuven /ID# 215684
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Universitair Ziekenhuis Leuven /ID# 218806
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
Universitair Ziekenhuis Leuven /ID# 240312
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT03891446Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
Universitair Ziekenhuis Leuven /ID# 246461
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT05618028Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Universitair Ziekenhuis Leuven /ID# 246671
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT06508658A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Universitair Ziekenhuis Leuven /ID# 251399
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT05601882A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Universitair Ziekenhuis Leuven /ID# 252457
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT05959070An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)
Universitair Ziekenhuis Leuven /ID# 269736
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT05041257Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
Universitair Ziekenhuis Leuven /ID# 275586
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT07005102A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Universitair Ziekenhuis Leuven /ID# 277350
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT06682988A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
Universitair Ziekenhuis Leuven /ID# 279439
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT07382440A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium
  Contact: Clementine Semanaz
UZ Leuven, campus Pellenberg
Pellenberg, 3212
1 vizsgálat
- NCT07124247Implementation of the MOX Activity Monitor in Hospitalized Geriatric Rehabilitation
UZ Leuven - Department of Gastroenterology and Hepatology
Leuven
1 vizsgálat
- NCT04882007Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
UZ Leuven - Digestive oncology
Leuven, Flemish Brabant 3000
1 vizsgálat
- NCT07811193A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
UZ Leuven /ID# 272781
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT06764693An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
  Contact: Shari Chapman
UZ Leuven, Neurologie Herestraat 49
Leuven, 3000
1 vizsgálat
- NCT04408625Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
UZ Leuven, Radiotherapy & Oncology
Leuven
1 vizsgálat
- NCT04459715A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
UZ Leuven (Site 0161)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04210115Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
UZ Leuven (Site 0205)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04003636Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)
UZ Leuven (Site 0377)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT03867084Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
UZ Leuven (Site 1004)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04662710Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)
UZ Leuven (Site 1101)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
UZ Leuven (Site 1300)
Leuven, Vlaams-Brabant 3000
1 vizsgálat
- NCT05446870Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)
UZ Leuven (Universitair Ziekenhuis Leuven)
Leuven, 3000
1 vizsgálat
- NCT06713135A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy
0560048 - Universitair Ziekenhuis (UZ) Leuven
Leuven, 3000
0560056 - Universitair Ziekenhuis Leuven
Leuven, 3000
Universitair Ziekenhuis Leuven /ID# 150468
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 157407
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 170829
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 200031
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 202779
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 208209
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 215006
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 218905
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 223901
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 225951
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 242384
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 247780
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 248598
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 251185
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 254089
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 255098
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 257079
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 258226
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 260304
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 261302
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 261740
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 263098
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 265519
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 268914
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 269308
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 269370
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 269957
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 272382
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 276316
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 276874
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 278668
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven /ID# 279330
Leuven, Vlaams-Brabant 3000
Universitair Ziekenhuis Leuven (UZ Leuven) - Campus Gasthuisberg
Leuven, 3000
Universitair Ziekenhuis (UZ) Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant 3000
UZ Leuven
Flemish Brabant, 3000
UZ Leuven
Gasthuisberg
UZ Leuven - Campus Gasthuisberg - Nuclear Medicine
Leuven, Flemish Brabant 3000
UZ Leuven - Campus Gasthuisberg (Site 1401)
Leuven, Vlaams-Brabant 3000
UZ Leuven - Centrum voor Moleculaire en Vasculaire Biologie
Leuven, 3000
UZ Leuven - E507 Studies IBD tav Tine Hermans
Leuven, 3000
UZ Leuven - Geheugenkliniek
Leuven, 3000
UZ Leuven - Internal Medicine
Leuven, 03000
UZ Leuven / Nephrology
Leuven, 3000
UZ Leuven - Neurochirurgie Campus Gasthuisberg
Leuven
UZ Leuven - Neurology department
Leuven, 3000
UZ Leuven - Pediatric Cardiology
Leuven, Flemish Brabant 3000
UZ Leuven (Site 0101)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0221)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0252)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0300)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0301)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0303)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0354)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0361)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0401)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0483)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0600)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0601)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 0700)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 1002)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 1301)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 1401)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 2001)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 2040)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 3000)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 3200)
Leuven, Antwerpen 3000
UZ Leuven (Site 3400)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Site 4402)
Leuven, Vlaams-Brabant 3000
UZ Leuven (Univ Ziekenhuis Leuven)
Leuven, 3000
UZ Leuven, UZ Leuven Campus Gasthuisberg, Herestraat 49
Leuven, 3000

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Colitis ulcerosa83 munka · 53 vizsgálat
Crohn-betegség78 munka · 44 vizsgálat
Petefészekrák36 munka · 57 vizsgálat
1-es típusú cukorbetegség35 munka · 13 vizsgálat
Bronchiectasis30 munka · 7 vizsgálat
Zöldhályog (glaukóma)29 munka · 4 vizsgálat
Amiotrófiás laterálszklerózis (ALS)26 munka · 20 vizsgálat
Krónikus obstruktív tüdőbetegség (COPD)25 munka · 14 vizsgálat
Cerebral palsy23 munka · 10 vizsgálat
Congenital heart disease20 munka · 2 vizsgálat
Frontotemporális demencia19 munka · 7 vizsgálat
Méhtestrák18 munka · 27 vizsgálat
Idiopátiás tüdőfibrózis17 munka · 17 vizsgálat
Cisztás fibrózis16 munka · 9 vizsgálat
Chronic rhinosinusitis with nasal polyps15 munka · 6 vizsgálat
Fej-nyaki daganatok13 munka · 18 vizsgálat
Neurofibromatosis type 113 munka · 0 vizsgálat
Cytomegalovirus infection12 munka · 4 vizsgálat
Gestational diabetes12 munka · 2 vizsgálat
Ventricular tachycardia11 munka · 1 vizsgálat
Policisztás vesebetegség11 munka · 6 vizsgálat
Neuroendokrin daganatok11 munka · 6 vizsgálat
Gyermekkori daganatok10 munka · 53 vizsgálat
Irritable bowel syndrome9 munka · 5 vizsgálat
Spinális izomatrófia (SMA)9 munka · 8 vizsgálat
Mielodiszplasztikus szindróma (MDS)7 munka · 12 vizsgálat
Thymoma and thymic carcinoma6 munka · 0 vizsgálat
Hemofília6 munka · 11 vizsgálat
Giant cell arteritis6 munka · 4 vizsgálat
Lewy-testes demencia6 munka · 5 vizsgálat

Intézményadatok: ROR 0424bsv16 (CC0-1.0)Frissítve: 2026. nov. 14.

Hibát jelzek